-
61Institutional Access to Gene Therapy for Sickle Cell Disease – Treatment on a Clinical Trial or Receive a Newly Approved Therapy?American Journal of Bioethics 25 (4): 145-146. 2025.The United States Food and Drug Administration (FDA) approved two gene therapies for sickle cell disease (SCD) in the Fall of 2023. SCD is an inherited disorder of abnormal hemoglobin production af...
Areas of Interest
| Meta-Ethics |
| Moral Reasoning and Motivation |
| Value Theory |